Isabel Preeshagul
@ipreeshagul
Thoracic Medical Oncologist @MSKCancercenter Passionate about #PCORI #Precisionmedicine #PRO Patient Education and Personalized Care. #LCSM
ID: 1481102035
04-06-2013 01:45:43
467 Tweet
1,1K Followers
964 Following
What an absolutely INCREDIBLE event ! Looking forward to learning from this star panel . we all should strive to be more and do more for our patients! The Patient-Centered Outcomes Research Institute
When you see a package on your desk from KRASKickers 🤍. Thank YOU for inspiring me! Living by this acronym : Knowledge Research Advocacy Survivorship Thanks to Lung Cancer Research Foundation for connecting us at the #togetherseparately event ! #patienteducation #PCORI #LCSM #PATIENTADVOCACY
📣THRILLED to be moderating #ASCO24 UPDATES in lung cancer joined by my Memorial Sloan Kettering Cancer Center RobertWoodJohnson colleagues ⌛️7/18 Thursday 6-9 PM 📝learn, network, eat! ✅LINK BELOW to register event.onclive.com/event/f2115ee7…
📢Could not emphasize the importance of these efforts more! Patient centricity - bringing high level care to you! This is what it’s all about! Thrilled this aspect of medicine is finally getting the attention it deserves! Robin Zon, MD, FACP, FASCO Dr Zon I applaud you!
📢 HONORED to host #ASCO24 Lung Cancer Updates joined by : Alissa Cooper, MD - ADCs Kathryn C. Arbour - KRAS Missak Haigentz ALK Dr Mark Kris - early stage Dr. Paul Paik - ROS-1 NRG1 Fernando Santini - EGFR Yours truly - SCLC 7/18/24 6-9PM EST Join us below 👇🏽! event.onclive.com/event/f2115ee7…
Fun @ #lungcancersummit w/ my Memorial Sloan Kettering Cancer Center fam & Missak Haigentz honorary member! Take 🏠 - NGS testing is 🔑 at diagnosis & progression -👀out for NVL 520 for ALK and Ros-1 -watch KRASg12D space -EGFR new options but tox is real and needs to be discussed risk vs benefit
LOVED joining Oncology Brothers to discuss selecting frontline tx for pts with stage IV dz w/out a driver. How do we choose? PDL1/TMB Co mutations STK11 keap1? Disease Burden Other Most importantly taking into consideration QoL and tox profile. Tune in to hear more ! #lcsm
On #WorldLungCancerDay2024 I am reminded of my reasons why: 🫁 lung cancer remains the leading cause of cancer deaths ⬆️focus on #pct 💊tox is real , regardless of grade. QoL imperative , bring care closer to 🏡 🧑🧑🧒🧒 Young Lung Cancer Initiative is a thing. We need to do better !
We had a special guest on rounds today 🥹 Memorial Sloan Kettering Cancer Center MSK Department of Medicine #therapydog
Take 🏡 from service with the amazing Memorial Sloan Kettering Cancer Center thoracic oncology APPs & pharmD! - advocate for your pt - document family discussions well - collaboration is 🔑put everyone on the same chain - call the family/ support contact when you round - always pet the therapy 🦮
So excited for #wclc24 ! Looking forward to many sessions including social media workshop and understanding and managing compassion fatigue- something we all can improve upon. Eric K. Singhi, MD Jhanelle Gray MD Jennifer Bickel Shani Shilo and Dr Pompili. IASLC
#WCLC24 faculty dinner with some of the very best people! Aakash Desai, MD, MPH Ana I. Velázquez Mañana, MD, MSc, FASCO Meera Ragavan, MD MPH Bruna Pellini, MD Isabel Preeshagul IASLC
YES TO THIS 👏🏽 Might I also add , reading ones chart and seeing “EGFR/KRAS mutant” “ prior smoker” “ pt not compliant” “pt refused” “ pt failed xyz” the list goes on. What we write/ how we speak matters. #WCLC2024 Make Cancer Less Shitty KRASKickers ALK Positive LiveLung
Honored to co-chair the novel ADC session w/ Mihaela Aldea ! Take 🏡 -✔️met/ her2 IHC -TelisoV and Tdxd have show efficacy in pre treated pts with 2/3+ expression -Tox is real, ILD and neuropathy seem to be most prevalent. - advocate for this testing to be done!
Exciting to have these options! 💬My question- how do you discuss this vs MARIPOSA-2 with your pts in clinic? 💬 thoughts on CNS efficacy? #lcsm EGFR Resisters